Jaguar Health, Inc.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| JAGUAR HEALTH, INC. | |
| By: | /s/ LISA A. CONTE |
| Lisa A. ConteChief Executive Officer and President |
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Lisa A. Conte and Carol Lizak, jointly and severally, his or her attorneys-in-fact, each with the power of substitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his or her substitute or substitutes, may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ LISA A. CONTE Lisa A. Conte | Chief Executive Officer, President and Director (Principal Executive Officer) | March 31, 2025 |
| /s/ CAROL LIZAK Carol Lizak | Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer) | March 31, 2025 |
| /s/ JAMES J. BOCHNOWSKI James J. Bochnowski | Chairman of the Board | March 31, 2025 |
| /s/ JOHN MICEK III John Micek III | Director | March 31, 2025 |
| /s/ JONATHAN B. SIEGEL Jonathan B. Siegel | Director | March 31, 2025 |
| /s/ ANULA JAYASURIYA Anula Jayasuriya | Director | March 31, 2025 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.